James (Jim) M. Wright obtained his MD from the University of Alberta in 1968, his FRCP(C) in Internal Medicine in 1975 and his Ph.D. in Pharmacology from McGill University in 1976. He is a practicing specialist in Internal Medicine and Clinical Pharmacology. He was Professor in the Departments of Anesthesiology, Pharmacology & Therapeutics and Medicine, University of BC, Vancouver, BC, between 1977 and 2019. Since 2020 he is Professor Emeritus. He was the Co-Managing Director of the Therapeutics Initiative and Editor-in-Chief of the Therapeutics Letter from 1994 to 2019. He is currently the Coordinating Editor of the Cochrane Hypertension Review Group and Academic Editor for PLoSONE. Dr. Wright’s research focuses on issues related to appropriate use and safety of prescription drugs, Clinical Pharmacology, clinical trials, systematic review, meta-analysis and knowledge translation.
The Dangers of Psychiatric Medication | Dr. Jim Wright & Dr. David Cohen – MP Podcast #83
SSRI withdrawal – something I didn’t know existed – gave me the worst psychiatric symptoms I’ve ever had for more than 2.5 years after I suddenly stopped taking them (not aware that you had to wean and that they’re dependency forming). If I hadn’t had the diet I’m on (the lion diet) I don’t know what I would have done. It was like I was in hell. Then almost right after I recovered my dad almost died from psych medication. I brought two experts on – Dr. Jim Wright and Dr. David Cohen – to discuss the actual reality behind psychiatric medications and pharmaceuticals and dependency and withdrawal and suicide. This is an episode everyone should listen to if they or a loved one is on psychiatric medication or considering one or acting strange after being medicated.
Ex-benzodiazepine user relating to Peterson says withdrawal ‘hell’ needs awareness
When Audrey Kellestine was prescribed a common drug to treat insomnia, she believed she could stop using it at any time.
Dr. Jim Wright Interview for Mad in America Benzodiazepine Podcast
Jim is Emeritus Professor in the Departments of Anesthesiology, Pharmacology, and Therapeutics in Medicine at the University of British Columbia. Jim obtained his MD from the University of Alberta in 1968, and his PhD in pharmacology from McGill University in 1976. He is a practicing specialist in internal medicine and clinical pharmacology. He is also Editor in Chief of the Therapeutics Letter and he sits on the editorial boards of PLoS One and the Cochrane Library. Dr. Wright’s research focuses on issues relating to the appropriate use of prescription drugs, clinical pharmacology, clinical trials, systematic review, meta-analysis, and knowledge translation.
Risks and Benefits of Benzodiazepines
To the Editor The recent Viewpoint about the risks and benefits of benzodiazepines1 dismissed the alarming statistics that 12.6% of people in the US are using benzodiazepines (4 times the rate in other high-income nations), 17% of them are misusing these drugs, and benzodiazepine-related deaths have…